Samlyn Capital’s Medtronic MDT Stock Holding History

Samlyn Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-379,600	Closed	-$20.2M	–	105
2013 Q3	$20.2M	Buy	+379,600	New	+$20.4M	0.56%	69

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Samlyn Capital's MDT Position: Q4 2013 in Review

Samlyn Capital sold out of Medtronic (MDT) in Q4 2013, closing a stake of 379,600 shares — an estimated $20.2M sold.

Samlyn Capital first reported a position in MDT in Q3 2013 and held it in 1 quarter. The position peaked at $20.2M in Q3 2013. 1,067 funds tracked by Wall St. Rank hold MDT as of Q4 2013.

Samlyn Capital reported no remaining Medtronic position as of Q4 2013 after selling out during the quarter.
Samlyn Capital sold 379,600 Medtronic shares in Q4 2013, an estimated $20.2M.
Samlyn Capital first reported a position in Medtronic in Q3 2013 and held it in 1 quarter.
Samlyn Capital's Medtronic position peaked at $20.2M in Q3 2013.
1,067 funds tracked by Wall St. Rank held Medtronic as of Q4 2013.

Based on Samlyn Capital's 13F filing for Q4 2013, filed 14 Feb 2014.